Tvardi Therapeutics Inc (TVRD) Stock Price, Quote & News

Company Profile

Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of novel, oral, and small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need in the United States. The company's lead product candidates include TTI-101, which is in Phase 2 clinical development stage for fibrosis-driven diseases with an initial focus on idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC); and TTI-109, an oral, small...

Industry: Biotechnology

Sector: Healthcare

Phone: 713 489 8654

Website: tvarditherapeutics.com

Address:

3 Sugar Creek Center Boulevard, Suite 525, Sugar Land, United States

Arjun_Singh_Rathore Oct. 24 at 8:08 PM

$TVRD at this price it's a bargain. I'd keep buying and just hold.

0 · Reply

Randolf0676 Oct. 24 at 2:21 PM

$TVRD i’m new here, and just bought at $5.50. Was worried about dilution, but my “quick DD” says they have sufficient cash… AGAIN, I’m new here and got in when it tanked 85%…

0 · Reply

nUme22 Oct. 23 at 5:03 PM

$TVRD this might just die in a qtr.. not enough cash, no potential.. 3 ?? maybe for dead catch bounce..

0 · Reply

NolAsrtormZ Oct. 23 at 8:29 AM

$GRI .... $TVRD down 300 million market cap, $PLRX down 900 million market cap, $ACRT down 300 million market cap $GRI market cap is 5.3 million with iPf data next. Do the math 🤑🤑🤑🤑

0 · Reply

Fakhrul123 Oct. 23 at 3:40 AM

$TVRD hopefully will see the rebound soon. Average is $11.5, but not panicking. Will see $50 end of the year. Big positive result coming up.

1 · Reply

NolAsrtormZ Oct. 22 at 8:03 PM

$GRI based on $TVRD $PLRX $ARCT 300 million market cap drops its.... $0 or $126

0 · Reply

r202950 Oct. 22 at 7:19 PM

$TVRD so what's going on today that this is doing so much?

1 · Reply

NolAsrtormZ Oct. 22 at 6:50 PM

$GRI ...Another 1 bites the dust🤪 so your telling me $ARCT lost 340 million market cap on failed fibrosis drug trial? $TVRD lost 300 million market cap Fail $PLRX lost 900 million market cap Fail Gri market cap 5.6million If we hit Data ipf should be about 300 million Market cap gain

0 · Reply

NolAsrtormZ Oct. 22 at 11:07 AM

$GRI Billion $$$$ iPf data market cap day for Gri???? $TVRD $PLRX $UTHR Market cap currently 5.6 million

1 · Reply

NolAsrtormZ Oct. 21 at 9:34 PM

$GRI .... $TVRD you guys ready to see gri iPf data and see if we collect the 300 million market cap you you lost on Failed ipf data? $PLRX you guys ready to see gri iPf data to see if we collect the 900 million market cap you lost on bad iPf data? $UTHR share the luv on iPf Market cap yo

0 · Reply

TVRD SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics

Oct 13, 2025, 6:27 PM EDT - 11 days ago

TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics

Oct 13, 2025, 2:23 PM EDT - 12 days ago

Tvardi Therapeutics' Lung Disease Candidate Fails To Show Any Clinical Benefit, Stock Sinks

Oct 13, 2025, 1:12 PM EDT - 12 days ago

Gold Rises Over 3%; Tvardi Therapeutics Shares Plunge

AAAU DGP GLD GLDM IAU OUNZ

Oct 13, 2025, 7:30 AM EDT - 12 days ago

Tvardi Therapeutics Provides Update on Preliminary Data from Phase 2 REVERT Trial in Idiopathic Pulmonary Fibrosis

Aug 21, 2025, 8:00 AM EDT - 2 months ago

Tvardi Therapeutics to Participate in the Cantor Global Healthcare Conference

Aug 14, 2025, 4:01 PM EDT - 2 months ago

Tvardi Therapeutics Announces Second Quarter 2025 Results and Provides Business Update

Jul 15, 2025, 8:00 AM EDT - 3 months ago

Tvardi Therapeutics to Participate in the BTIG Virtual Biotechnology Conference

Jun 12, 2025, 3:07 PM EDT - 4 months ago

Recently Listed Tvardi Therapeutics' Lead Drug 'Positioned To Drive Broad Improvement', Analyst Sees Over 150% Stock Upside

May 27, 2025, 8:00 AM EDT - 5 months ago

Tvardi Therapeutics Announces Completion of Enrollment in Phase 2 Clinical Trial of TTI-101 in Idiopathic Pulmonary Fibrosis

May 20, 2025, 8:00 AM EDT - 5 months ago

Tvardi Therapeutics to Participate in Upcoming Investor Conferences

May 13, 2025, 4:05 PM EDT - 5 months ago

Tvardi Therapeutics Announces First Quarter 2025 Results and Provides Business Update

May 6, 2025, 7:00 AM EDT - 6 months ago

Tvardi Therapeutics Announces Presentation at the American Thoracic Society 2025 Annual Conference

Apr 15, 2025, 4:05 PM EDT - 6 months ago

Tvardi Therapeutics Announces Closing of Merger with Cara Therapeutics

CARA

Arjun_Singh_Rathore Oct. 24 at 8:08 PM

$TVRD at this price it's a bargain. I'd keep buying and just hold.

0 · Reply

Randolf0676 Oct. 24 at 2:21 PM

$TVRD i’m new here, and just bought at $5.50. Was worried about dilution, but my “quick DD” says they have sufficient cash… AGAIN, I’m new here and got in when it tanked 85%…

0 · Reply

nUme22 Oct. 23 at 5:03 PM

$TVRD this might just die in a qtr.. not enough cash, no potential.. 3 ?? maybe for dead catch bounce..

0 · Reply

NolAsrtormZ Oct. 23 at 8:29 AM

$GRI .... $TVRD down 300 million market cap, $PLRX down 900 million market cap, $ACRT down 300 million market cap $GRI market cap is 5.3 million with iPf data next. Do the math 🤑🤑🤑🤑

0 · Reply

Fakhrul123 Oct. 23 at 3:40 AM

$TVRD hopefully will see the rebound soon. Average is $11.5, but not panicking. Will see $50 end of the year. Big positive result coming up.

1 · Reply

NolAsrtormZ Oct. 22 at 8:03 PM

$GRI based on $TVRD $PLRX $ARCT 300 million market cap drops its.... $0 or $126

0 · Reply

r202950 Oct. 22 at 7:19 PM

$TVRD so what's going on today that this is doing so much?

1 · Reply

NolAsrtormZ Oct. 22 at 6:50 PM

0 · Reply

NolAsrtormZ Oct. 22 at 11:07 AM

$GRI Billion $$$$ iPf data market cap day for Gri???? $TVRD $PLRX $UTHR Market cap currently 5.6 million

1 · Reply

NolAsrtormZ Oct. 21 at 9:34 PM

0 · Reply

NolAsrtormZ Oct. 21 at 4:19 PM

$GRI only a few tickers know how much iPf data is worth. $PLRX lost 900 million market cap for ipf data $TVRD lost 300 million market cap for ipf data $FGEN went from $16 to $3.00 on ipf data Gri market cap. 5 million

0 · Reply

hunanddone Oct. 21 at 2:26 PM

$TVRD Man, I wanted to play this like MLTX so badly. Buy 100,000 shares and after a 90% drop it pops from $5 to 10 and you make a half mil but I think the big diff is what does the company have in the pipeline besides the one that just tanked cuz of a trial failure. If nothing.... its a slow cash burn and no pop. Invite commentary

3 · Reply

NolAsrtormZ Oct. 21 at 1:35 PM

$GRI trades at 5 million market cap. BIllion $$$ ipf data market not priced in yet. $UTHR $TVRD $PLRX Gri $2.05

0 · Reply

NolAsrtormZ Oct. 21 at 12:04 PM

$GRI how much market cap did $TVRD lose for failed ipf dat??? 300 million market cap So does that mean ipf data is worth at Least 300 million market cap

0 · Reply

Peprep24 Oct. 20 at 6:55 PM

$TVRD where is the bottom?

1 · Reply

NolAsrtormZ Oct. 20 at 11:52 AM

$GRI .... $TVRD failed iPf data lost 300 million market cap $PLRX discontinued ipf data lost 900 million market cap $FGEN failed ipf data went from $16 to $3 Billion $$$ market cap for ipf data =

0 · Reply

Fakhrul123 Oct. 20 at 9:56 AM

$TVRD $8 today?

1 · Reply

NolAsrtormZ Oct. 18 at 12:12 AM

$GRI surely w OK ipf data we could accomplish what $TVRD market cap is🤑🤑🤑🤑

0 · Reply

NolAsrtormZ Oct. 18 at 12:10 AM

$GRI Even with Failed iPf data $TVRD still trades at aprx 62million market cap

0 · Reply

aaronjohnjohn007 Oct. 17 at 7:25 PM

$TVRD is anyone having trouble buying this?when i try i get this message is there something in the news i missed?

1 · Reply

NolAsrtormZ Oct. 17 at 5:45 PM

$TVRD How many years until the next Data readout???? Lost over 300 million n Market cap w a big Fail $GRI bio next on deck for the iPf data. Hope to get that $300 million market cap u lost🤑🤐🤑🤑 $GRI trades at $1.90

0 · Reply

Fakhrul123 Oct. 16 at 11:18 PM

$TVRD I know many shareholders who r at $20+ average. They know it’s bad time but not panicking. We’re waiting for something better coming out soon. Holding average $13.44 3100 shares. See you over $20 soon

0 · Reply

Market Cap	48.39M
Revenue (ttm)	7.14M
Net Income (ttm)	-70.87M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-992.58%
Debt to Equity Ratio	0.00

Volume	260,000
Avg Vol	291,074
Day's Range	N/A - N/A
Shares Out	9.38M
Stochastic %K	3%
Beta	0.24
Analysts	Sell
Price Target	$16.00